PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy (PIR-008/K)
This study is ongoing, but not recruiting participants.
Sponsor:
Desitin Arzneimittel GmbH
Information provided by (Responsible Party):
Desitin Arzneimittel GmbH
ClinicalTrials.gov Identifier:
NCT01519856
First received: March 12, 2010
Last updated: February 28, 2013
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2015 |
| Estimated Primary Completion Date: | November 2014 (Final data collection date for primary outcome measure) |